Kassouf W - Search Results

1

Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells.

Kassouf W, Dinney CP, Brown G, McConkey DJ, Diehl AJ, Bar-Eli M, Adam L. Kassouf W, et al. Cancer Res. 2005 Nov 15;65(22):10524-35. doi: 10.1158/0008-5472.CAN-05-1536. Cancer Res. 2005. PMID: 16288045

2

Clinical applications for targeted therapy in bladder cancer.

Adam L, Kassouf W, Dinney CP. Adam L, et al. Among authors: kassouf w. Urol Clin North Am. 2005 May;32(2):239-46, vii. doi: 10.1016/j.ucl.2005.02.004. Urol Clin North Am. 2005. PMID: 15862621 Review.

3

Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.

Kassouf W, Chintharlapalli S, Abdelrahim M, Nelkin G, Safe S, Kamat AM. Kassouf W, et al. Cancer Res. 2006 Jan 1;66(1):412-8. doi: 10.1158/0008-5472.CAN-05-2755. Cancer Res. 2006. PMID: 16397256

4

Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: is there a benefit to either approach?

Spiess PE, Kassouf W, Brown G, Highshaw R, Wang X, Do KA, Kamat AM, Czerniak B, Dinney CP, Grossman HB. Spiess PE, et al. Among authors: kassouf w. Urology. 2006 Mar;67(3):466-71. doi: 10.1016/j.urology.2005.09.043. Urology. 2006. PMID: 16527559

5

Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.

Kassouf W, Swanson D, Kamat AM, Leibovici D, Siefker-Radtke A, Munsell MF, Grossman HB, Dinney CP. Kassouf W, et al. J Urol. 2006 Jun;175(6):2058-62. doi: 10.1016/S0022-5347(06)00322-3. J Urol. 2006. PMID: 16697803

6

Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy.

Kassouf W, Leibovici D, Munsell MF, Dinney CP, Grossman HB, Kamat AM. Kassouf W, et al. J Urol. 2006 Jul;176(1):53-7; discussion 57. doi: 10.1016/S0022-5347(06)00510-6. J Urol. 2006. PMID: 16753366

7

Schedule dependent efficacy of gefitinib and docetaxel for bladder cancer.

Kassouf W, Luongo T, Brown G, Adam L, Dinney CP. Kassouf W, et al. J Urol. 2006 Aug;176(2):787-92. doi: 10.1016/j.juro.2006.03.072. J Urol. 2006. PMID: 16813948

8

Relevance of extracapsular extension of pelvic lymph node metastasis in patients with bladder cancer treated in the contemporary era.

Kassouf W, Leibovici D, Luongo T, Munsell MF, Vakar F, Dinney CP, Grossman HB, Kamat AM. Kassouf W, et al. Cancer. 2006 Oct 1;107(7):1491-5. doi: 10.1002/cncr.22139. Cancer. 2006. PMID: 16894527 Free article.

9

Vitamins C and K3 sensitize human urothelial tumors to gemcitabine.

Kassouf W, Highshaw R, Nelkin GM, Dinney CP, Kamat AM. Kassouf W, et al. J Urol. 2006 Oct;176(4 Pt 1):1642-7. doi: 10.1016/j.juro.2006.06.042. J Urol. 2006. PMID: 16952707

10

Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.

Spiess PE, Brown GA, Liu P, Tu SM, Tannir NM, Evans JG, Kamat AM, Kassouf W, Pisters LL. Spiess PE, et al. Among authors: kassouf w. J Urol. 2007 Jan;177(1):131-8. doi: 10.1016/j.juro.2006.08.092. J Urol. 2007. PMID: 17162023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters